Things I read yesterday as part of my stock research activities.
New Orders Received
🟢 HBL Engineering wins order worth ₹180 Cr. HBL has been diversifying from traditional battery and railway electronics into broader defence and energy storage orders.
🟢 Astra Microwave JV Astrra Rafael Comsys receives order worth ₹250.58 Cr from Hindustan Aeronautics Limited for supply of Software Defined Radio. SDR is a key element of HAL's platform modernisation. This order validates the Astra-Rafael JV's competitive positioning in Indian defence avionics.
Partnerships, Investments & Acquisitions
🟢 Krishna Institute of Medical Sciences unit enters a 20-year operations and management agreement with Avitis Super Speciality Hospitals. O&M agreements are capital-light. KIMS effectively expands managed bed capacity without balance sheet burden.
🟢 Emami acquires 100% stake in Axiom Ayurveda (brand 'Alofrut') for ₹200 Cr to enter the beverage sector. Alofrut's ayurvedic fruit drink positioning gives Emami a natural adjacency to its existing wellness and FMCG distribution network.
🟢 Zaggle Prepaid Ocean Services infuses ₹50 Cr into Rivpe Tech, acquiring a strategic stake for fintech expansion. Embedded fintech services have higher LTV than standalone prepaid card products.
Core Business & Regulatory
🟢 Apollo Hospitals Enterprise approves establishment of a multi-speciality hospital at Dwarka, New Delhi with a 55-year land license and annual fee of ₹33 Cr from the fifth year. Dwarka gives Apollo access to a dense, underserved West Delhi area where it currently has no major footprint.
🟢 Ashok Leyland plans to expand its addressable market in the LCV segment from 54% to 80% over the next 3-4 years by entering sub-2-tonne, 4-6-tonne, and small passenger vehicle categories.
🟢 LG Electronics India sells over 1 million ACs in Q1 CY26, showing India market dominance.
🔴 Hariom Pipe Industries faces temporary closure at its Perundurai unit following TNPCB directions.
Economy, IPO & Other
🔴 India Manufacturing PMI for March came in at 53.9 vs 56.9 previous, indicating a slowdown in manufacturing activity.
🔴 US prepares to impose new tariffs on pharmaceutical imports. India supplies roughly 30% of US generic drug volumes. Sun Pharma, Cipla, and Dr Reddy's together generate over $3.5 Bn annually from the US market.
🔴 Gas crunch hits Firozabad's glass industry as the West Asia conflict continues. Firozabad accounts for roughly 70% of India's glass bangle production.
That’s it for today.
FINVEZTO.COM | Build Wealth. With Clarity.
Disclaimer: Anand Ganapathy K is a SEBI-registered Research Analyst with SEBI registration number INH000016630. This post is purely for learning purposes. We do not recommend buying or selling stocks mentioned in this newsletter. Securities market investments carry market risks. Kindly review all related documents before investing.